PSEN1 and Alzheimer disease: In the APP/PS1 mutant mouse model of Alzheimer’s disease, PCA treatment was found to reduce amyloid beta deposition in hippocampal tissue, in addition to reducing expression of APP, from which amyloid beta is generated [223].